Q1 2013 Earnings Estimate $0.00 EPS***Breakeven****Revenue Est $7.47 Million
It is very difficult to estimate as there is no good source of direct or even indirect quatifiable indicators. ISRG reported 69 Firefly sales vs 88 Q4 and 64 Q3 2012. I estimate 45 vs 47 Q4 and 44 Q3 2012 SPY Elites from Life Cell. The unknown wild card are the PINPOINTs. 2 sold in Q4, I have 10 this quarter but that is based on speculative gut feelings only. They reported 10 sales and marketing people last quarter for PINPOINT and that they should be producing ~$1 million in revenue per year per person after 6-12 months. The question is how many early adopters or hospitals hearing of the preliminary/interim reports from the PILLAR study acted in Q1? I expect the cost side to ramp up faster than the revenues because of the 6-12 month lag, but the results are so compelling there may be some early adopters that want to have the competitive advantages of this new technology. Anachdotally I found a number of hospitals that were doing just this on their web sites. Warrants should have little impact this time as the closing price at Q4 and Q1 were about the same.
All contributions, remarks or other inputs are welcome.
Iron sharpens Iron. Proverbs 27:17
Actual revenues $7.3M - EPS (excluding warrant revalution) of -$0.02. so just missed. 200 units of Spy Elite and Firefly shipped in Q1, with an increase of 130 on the installed - I think that is a record! Momentum is building - by this time next year, LUNA and PinPoint will be contributing to the exponential revenue and earnings growth - the next few years will be very interesting.